GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (TSE:4592) » Definitions » EPS (Diluted)

SanBio Co (TSE:4592) EPS (Diluted) : 円-32.05 (TTM As of Jul. 2024)


View and export this data going back to 2015. Start your Free Trial

What is SanBio Co EPS (Diluted)?

SanBio Co's Earnings per Share (Diluted) for the three months ended in Jul. 2024 was 円-16.98. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2024 was 円-32.05.

SanBio Co's EPS (Basic) for the three months ended in Jul. 2024 was 円-16.98. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jul. 2024 was 円-31.99.

SanBio Co's EPS without NRI for the three months ended in Jul. 2024 was 円-16.98. Its EPS without NRI for the trailing twelve months (TTM) ended in Jul. 2024 was 円-34.96.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


SanBio Co EPS (Diluted) Historical Data

The historical data trend for SanBio Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co EPS (Diluted) Chart

SanBio Co Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -100.91 -65.38 -90.33 -95.99 -40.48

SanBio Co Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.91 -1.46 -11.49 -2.12 -16.98

Competitive Comparison of SanBio Co's EPS (Diluted)

For the Biotechnology subindustry, SanBio Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SanBio Co's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SanBio Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where SanBio Co's PE Ratio falls into.



SanBio Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

SanBio Co's Diluted EPS for the fiscal year that ended in Jan. 2024 is calculated as

Diluted EPS (A: Jan. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2644.332-0)/65.323
=-40.48

SanBio Co's Diluted EPS for the quarter that ended in Jul. 2024 is calculated as

Diluted EPS (Q: Jul. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1164.276-0)/68.632
=-16.96

EPS (Diluted) for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-32.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SanBio Co  (TSE:4592) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


SanBio Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of SanBio Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


SanBio Co Business Description

Traded in Other Exchanges
N/A
Address
8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co Headlines

No Headlines